This milestone marks the first randomized control trial examining the efficacy of Rocket VR Health's immersive distress management digital therapeutic.
At Rocket VR Health, we are transforming the mental health treatment landscape by offering the next generation of digital therapeutics by leveraging proven clinical programs and ultra-realistic 3D environments, Cognitive Behavioral Therapy (CBT) games, and VR-enhanced meditations.
We are excited to continue our work with Dr. Areej El-Jawahri, Associate Professor of Medicine at Harvard Medical School and Director of Digital Health at the Mass General Cancer Center, and Dr. Hermioni L. Amonoo, Assistant Professor of Psychiatry at Harvard Medical School and Associate Program Director of Psychiatry at Brigham and Women's Hospital. Their expertise and leadership in the field will be invaluable to us as we pursue rigorous clinical evidence researching the efficacy of our virtual reality digital therapeutic.
Doctor Hologram Therapy Lesson
This exciting collaboration is exploring the preliminary efficacy of our virtual reality (VR) digital therapeutic in improving the quality of life, symptom burden, psychological distress, and self-efficacy in adult patients with blood cancers admitted for hematopoietic stem cell transplantation (HCT) at MGH.
Patients undergoing this type of treatment experience immense physical and psychological symptoms during a prolonged four-week hospitalization and endure significant short-term and long-term distress that affects their quality of life and their physical and psychological well-being. This trial is a significant milestone in our mission to transform mental health treatments with interactive mindfulness meditations and evidence-based digital therapeutics.
Our therapeutic recovery program leverages lessons learned from evidence-based palliative care interventions for patients undergoing HCT that were studied for years by the MGH team. The comprehensive 4-week therapeutic intervention combines interactive therapeutic experiences, high-definition doctor holograms, and meditations taking place at breathtaking nature-based locations.
Immersive Nature Environments part of the program
The therapeutic content is delivered on standalone Pico Neo 3 headsets that use a Qualcomm XR2 processor for next-generation performance and have over 2.5 hours of battery life. The headsets weigh only 1.3 pounds and have an ergonomic design while leveraging gaze-based controls removing the need for physical controllers ( controllers are still available if required ).
We believe that our digital therapeutic has the potential to change the paradigm of supportive care delivery for hospitalized patients with cancer. This study will guide us towards validating the efficacy of our digital therapeutic in our effort to build the go-to distress management solution for hospitalized patients.
This study is just the beginning of what is possible when technology and healthcare come together to improve the lives of patients and their caregivers.